{"title":"[急性Stanford B型主动脉夹层合并胸腔积液的危险因素分析及腔内修复后疗效观察]。","authors":"L F Zheng, D J Meng, Y S Wang, T N Zhou, X Z Wang","doi":"10.3760/cma.j.cn112138-20220904-00653","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> To investigate the risk factors of acute Stanford type B aortic dissection (TBAD) complicated with pleural effusion (PE) and the short-term and long-term outcomes of thoracic endovascular aortic repair (TEVAR). <b>Methods:</b> A case-control study. The clinical and imaging data of 1 083 patients with acute TBAD admitted to the General Hospital of Northern Theater Command from April 2002 to December 2020 were retrospectively analyzed, including 211 cases with pleural effusion and 872 cases without pleural effusion. The baseline analysis of the two groups of patients was performed. The risk factors associated with pleural effusion were analyzed by binary logistic regression, and the results were expressed as odds ratio (<i>OR</i>) and 95% confidence interval (<i>CI</i>). According to the quantity of pleural effusion, they were simultaneously divided into small pleural effusion group and medium large pleural effusion group, to compare the short-term and long-term effects of TEVAR patients with different amounts of pleural effusion. <b>Results:</b> The incidence of pericardial effusion (17.5% vs. 3.8%, <i>P</i><0.001), anemia (21.3% vs. 12.5%, <i>P</i>=0.001), aortic spiral tear (49.8% vs. 37.8%, <i>P</i>=0.002), dissection tear over diaphragm (57.8% vs. 48.1%, <i>P</i>=0.011), serum creatinine [85 (69, 111) vs. 81 (67, 100) μmol/L, <i>P</i>=0.011] and white blood cell levels[(11.3±4.2)×10<sup>9</sup>/L vs. (10.3±4.2)×10<sup>9</sup>/L, <i>P</i>=0.002] in acute TBAD pleural effusion group were significantly higher than those in non-pleural effusion group, and the hemoglobin level was significantly lower than that in non-pleural effusion group [(128±20) vs. (133±17) g/L, <i>P</i><0.05]. Logistic stepwise regression analysis showed that pericardial effusion (<i>OR</i>=5.038,95%<i>CI</i> 2.962-8.568,<i>P</i><0.001), anemia (<i>OR</i>=2.047,95%<i>CI</i> 1.361-3.079,<i>P</i>=0.001), spiral tear (<i>OR</i>=1.551,95%<i>CI</i> 1.030-2.336<i>, P</i>=0.002) and elevated white blood cell (<i>OR</i>=1.059,95%<i>CI</i> 1.011-1.102, <i>P</i>=0.005) were independent risk factors for TBAD complicated with pleural effusion. The incidences of all-cause death (4/19 vs. 1.5% vs. 0.9%, <i>P</i><0.001), aortogenic death (4/19 vs. 0.7% vs. 0.7%, <i>P</i><0.001) and aortic related adverse events (4/19 vs. 1.5% vs. 1.1%, <i>P</i><0.001) in patients with large pleural effusion during TEVAR operation were significantly higher than those in patients with small pleural effusion and those without pleural effusion, and the differences were statistically significant. At 1 month follow-up after TEVAR, the incidence of all-cause death (4/16 vs. 3.3% vs. 1.6%, <i>P</i><0.001), aortogenic death (4/16 vs. 0.8% vs.0.7%, <i>P</i><0.001), aorta related adverse events (4/16 vs. 4.1% vs. 4.7%, <i>P</i>=0.013) and overall clinical adverse events (4/16 vs.9.8% vs. 6.7%, <i>P</i>=0.014) in the medium and large thoracic group were significantly higher than those in the small pleural effusion group and no pleural effusion group, and the differences were statistically significant. At 1 year follow-up after TEVAR, the incidence of all-cause death (4/15 vs. 4.9% vs. 3.9%, <i>P</i>=0.004), aortogenic death (4/15 vs.2.5% vs. 2.1%, <i>P</i><0.001), aorta related adverse events (5/15 vs. 11.5% vs. 9.4%, <i>P</i>=0.012) and overall clinical adverse events (5/15 vs. 18.9% vs. 13.1%, <i>P</i>=0.029) in the medium and large thoracic group were significantly higher than those in the small pleural effusion group and no pleural effusion group, and the differences were statistically significant. <b>Conclusions:</b> Single center data showed that pericardial effusion, anemia, spiral tear and elevated white blood cell were independent risk factors for acute TBAD complicated with pleural effusion; the early (1 month) and long-term (1 year) rates of all-cause death, aortic mortality, aortic adverse events and overall clinical adverse events were significantly higher in TBAD patients with moderate pleural effusion after TEVAR, and moderate and large pleural effusion was an independent risk factor for near and long-term aortic related adverse events after TEVAR surgery.</p>","PeriodicalId":24000,"journal":{"name":"Zhonghua nei ke za zhi","volume":"62 8","pages":"964-971"},"PeriodicalIF":0.0000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Analysis of risk factors associated with acute Stanford type B aortic dissection complicated with pleural effusion and observation of the curative effect after intracavitary repair].\",\"authors\":\"L F Zheng, D J Meng, Y S Wang, T N Zhou, X Z Wang\",\"doi\":\"10.3760/cma.j.cn112138-20220904-00653\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Objective:</b> To investigate the risk factors of acute Stanford type B aortic dissection (TBAD) complicated with pleural effusion (PE) and the short-term and long-term outcomes of thoracic endovascular aortic repair (TEVAR). <b>Methods:</b> A case-control study. The clinical and imaging data of 1 083 patients with acute TBAD admitted to the General Hospital of Northern Theater Command from April 2002 to December 2020 were retrospectively analyzed, including 211 cases with pleural effusion and 872 cases without pleural effusion. The baseline analysis of the two groups of patients was performed. The risk factors associated with pleural effusion were analyzed by binary logistic regression, and the results were expressed as odds ratio (<i>OR</i>) and 95% confidence interval (<i>CI</i>). According to the quantity of pleural effusion, they were simultaneously divided into small pleural effusion group and medium large pleural effusion group, to compare the short-term and long-term effects of TEVAR patients with different amounts of pleural effusion. <b>Results:</b> The incidence of pericardial effusion (17.5% vs. 3.8%, <i>P</i><0.001), anemia (21.3% vs. 12.5%, <i>P</i>=0.001), aortic spiral tear (49.8% vs. 37.8%, <i>P</i>=0.002), dissection tear over diaphragm (57.8% vs. 48.1%, <i>P</i>=0.011), serum creatinine [85 (69, 111) vs. 81 (67, 100) μmol/L, <i>P</i>=0.011] and white blood cell levels[(11.3±4.2)×10<sup>9</sup>/L vs. (10.3±4.2)×10<sup>9</sup>/L, <i>P</i>=0.002] in acute TBAD pleural effusion group were significantly higher than those in non-pleural effusion group, and the hemoglobin level was significantly lower than that in non-pleural effusion group [(128±20) vs. (133±17) g/L, <i>P</i><0.05]. Logistic stepwise regression analysis showed that pericardial effusion (<i>OR</i>=5.038,95%<i>CI</i> 2.962-8.568,<i>P</i><0.001), anemia (<i>OR</i>=2.047,95%<i>CI</i> 1.361-3.079,<i>P</i>=0.001), spiral tear (<i>OR</i>=1.551,95%<i>CI</i> 1.030-2.336<i>, P</i>=0.002) and elevated white blood cell (<i>OR</i>=1.059,95%<i>CI</i> 1.011-1.102, <i>P</i>=0.005) were independent risk factors for TBAD complicated with pleural effusion. The incidences of all-cause death (4/19 vs. 1.5% vs. 0.9%, <i>P</i><0.001), aortogenic death (4/19 vs. 0.7% vs. 0.7%, <i>P</i><0.001) and aortic related adverse events (4/19 vs. 1.5% vs. 1.1%, <i>P</i><0.001) in patients with large pleural effusion during TEVAR operation were significantly higher than those in patients with small pleural effusion and those without pleural effusion, and the differences were statistically significant. At 1 month follow-up after TEVAR, the incidence of all-cause death (4/16 vs. 3.3% vs. 1.6%, <i>P</i><0.001), aortogenic death (4/16 vs. 0.8% vs.0.7%, <i>P</i><0.001), aorta related adverse events (4/16 vs. 4.1% vs. 4.7%, <i>P</i>=0.013) and overall clinical adverse events (4/16 vs.9.8% vs. 6.7%, <i>P</i>=0.014) in the medium and large thoracic group were significantly higher than those in the small pleural effusion group and no pleural effusion group, and the differences were statistically significant. At 1 year follow-up after TEVAR, the incidence of all-cause death (4/15 vs. 4.9% vs. 3.9%, <i>P</i>=0.004), aortogenic death (4/15 vs.2.5% vs. 2.1%, <i>P</i><0.001), aorta related adverse events (5/15 vs. 11.5% vs. 9.4%, <i>P</i>=0.012) and overall clinical adverse events (5/15 vs. 18.9% vs. 13.1%, <i>P</i>=0.029) in the medium and large thoracic group were significantly higher than those in the small pleural effusion group and no pleural effusion group, and the differences were statistically significant. <b>Conclusions:</b> Single center data showed that pericardial effusion, anemia, spiral tear and elevated white blood cell were independent risk factors for acute TBAD complicated with pleural effusion; the early (1 month) and long-term (1 year) rates of all-cause death, aortic mortality, aortic adverse events and overall clinical adverse events were significantly higher in TBAD patients with moderate pleural effusion after TEVAR, and moderate and large pleural effusion was an independent risk factor for near and long-term aortic related adverse events after TEVAR surgery.</p>\",\"PeriodicalId\":24000,\"journal\":{\"name\":\"Zhonghua nei ke za zhi\",\"volume\":\"62 8\",\"pages\":\"964-971\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Zhonghua nei ke za zhi\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3760/cma.j.cn112138-20220904-00653\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zhonghua nei ke za zhi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3760/cma.j.cn112138-20220904-00653","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的:探讨急性Stanford B型主动脉夹层(TBAD)合并胸腔积液(PE)的危险因素及胸血管内主动脉修复术(TEVAR)的近期和远期疗效。方法:病例-对照研究。回顾性分析2002年4月至2020年12月北方战区总医院收治的1 083例急性TBAD患者的临床及影像学资料,其中有胸腔积液211例,无胸腔积液872例。对两组患者进行基线分析。采用二元logistic回归分析与胸腔积液相关的危险因素,结果以比值比(OR)和95%置信区间(CI)表示。根据胸腔积液量同时分为小胸腔积液组和中大胸腔积液组,比较不同胸腔积液量TEVAR患者的近期和远期疗效。结果:急性TBAD胸腔积液组心包积液(17.5% vs. 3.8%, PP=0.001)、主动脉螺旋撕裂(49.8% vs. 37.8%, P=0.002)、横膈膜夹层撕裂(57.8% vs. 48.1%, P=0.011)、血清肌酐[85 (69,111)vs. 81 (67, 100) μmol/L, P=0.011]、白细胞水平[(11.3±4.2)×109/L vs(10.3±4.2)×109/L, P=0.002]的发生率均显著高于非胸腔积液组;血红蛋白水平明显低于非胸腔积液组[(128±20)∶(133±17)g/L, POR=5.038,95%CI 2.962 ~ 8.568,POR=2.047,95%CI 1.361 ~ 3.079,P=0.001]、螺旋撕裂(OR=1.551,95%CI 1.030 ~ 2.336, P=0.002)和白细胞升高(OR=1.059,95%CI 1.011 ~ 1.102, P=0.005)是TBAD合并胸腔积液的独立危险因素。中、大胸组全因死亡发生率(4/19 vs. 1.5% vs. 0.9%, PPPPPP=0.013)和总临床不良事件发生率(4/16 vs.9.8% vs. 6.7%, P=0.014)均显著高于小胸液组和无胸液组,差异有统计学意义。TEVAR术后随访1年,中、大胸组全因死亡发生率(4/15比4.9%比3.9%,P=0.004)、主动脉源性死亡发生率(4/15比2.5%比2.1%,PP=0.012)、总临床不良事件发生率(5/15比18.9%比13.1%,P=0.029)均显著高于小胸膜积液组和无胸膜积液组,差异有统计学意义。结论:单中心资料显示心包积液、贫血、螺旋撕裂和白细胞升高是急性TBAD合并胸腔积液的独立危险因素;TBAD患者TEVAR术后合并中度胸膜积液的早期(1个月)和长期(1年)全因死亡率、主动脉死亡率、主动脉不良事件和总体临床不良事件发生率均显著高于TBAD患者,且中度和大量胸膜积液是TEVAR术后近期和长期主动脉相关不良事件的独立危险因素。
[Analysis of risk factors associated with acute Stanford type B aortic dissection complicated with pleural effusion and observation of the curative effect after intracavitary repair].
Objective: To investigate the risk factors of acute Stanford type B aortic dissection (TBAD) complicated with pleural effusion (PE) and the short-term and long-term outcomes of thoracic endovascular aortic repair (TEVAR). Methods: A case-control study. The clinical and imaging data of 1 083 patients with acute TBAD admitted to the General Hospital of Northern Theater Command from April 2002 to December 2020 were retrospectively analyzed, including 211 cases with pleural effusion and 872 cases without pleural effusion. The baseline analysis of the two groups of patients was performed. The risk factors associated with pleural effusion were analyzed by binary logistic regression, and the results were expressed as odds ratio (OR) and 95% confidence interval (CI). According to the quantity of pleural effusion, they were simultaneously divided into small pleural effusion group and medium large pleural effusion group, to compare the short-term and long-term effects of TEVAR patients with different amounts of pleural effusion. Results: The incidence of pericardial effusion (17.5% vs. 3.8%, P<0.001), anemia (21.3% vs. 12.5%, P=0.001), aortic spiral tear (49.8% vs. 37.8%, P=0.002), dissection tear over diaphragm (57.8% vs. 48.1%, P=0.011), serum creatinine [85 (69, 111) vs. 81 (67, 100) μmol/L, P=0.011] and white blood cell levels[(11.3±4.2)×109/L vs. (10.3±4.2)×109/L, P=0.002] in acute TBAD pleural effusion group were significantly higher than those in non-pleural effusion group, and the hemoglobin level was significantly lower than that in non-pleural effusion group [(128±20) vs. (133±17) g/L, P<0.05]. Logistic stepwise regression analysis showed that pericardial effusion (OR=5.038,95%CI 2.962-8.568,P<0.001), anemia (OR=2.047,95%CI 1.361-3.079,P=0.001), spiral tear (OR=1.551,95%CI 1.030-2.336, P=0.002) and elevated white blood cell (OR=1.059,95%CI 1.011-1.102, P=0.005) were independent risk factors for TBAD complicated with pleural effusion. The incidences of all-cause death (4/19 vs. 1.5% vs. 0.9%, P<0.001), aortogenic death (4/19 vs. 0.7% vs. 0.7%, P<0.001) and aortic related adverse events (4/19 vs. 1.5% vs. 1.1%, P<0.001) in patients with large pleural effusion during TEVAR operation were significantly higher than those in patients with small pleural effusion and those without pleural effusion, and the differences were statistically significant. At 1 month follow-up after TEVAR, the incidence of all-cause death (4/16 vs. 3.3% vs. 1.6%, P<0.001), aortogenic death (4/16 vs. 0.8% vs.0.7%, P<0.001), aorta related adverse events (4/16 vs. 4.1% vs. 4.7%, P=0.013) and overall clinical adverse events (4/16 vs.9.8% vs. 6.7%, P=0.014) in the medium and large thoracic group were significantly higher than those in the small pleural effusion group and no pleural effusion group, and the differences were statistically significant. At 1 year follow-up after TEVAR, the incidence of all-cause death (4/15 vs. 4.9% vs. 3.9%, P=0.004), aortogenic death (4/15 vs.2.5% vs. 2.1%, P<0.001), aorta related adverse events (5/15 vs. 11.5% vs. 9.4%, P=0.012) and overall clinical adverse events (5/15 vs. 18.9% vs. 13.1%, P=0.029) in the medium and large thoracic group were significantly higher than those in the small pleural effusion group and no pleural effusion group, and the differences were statistically significant. Conclusions: Single center data showed that pericardial effusion, anemia, spiral tear and elevated white blood cell were independent risk factors for acute TBAD complicated with pleural effusion; the early (1 month) and long-term (1 year) rates of all-cause death, aortic mortality, aortic adverse events and overall clinical adverse events were significantly higher in TBAD patients with moderate pleural effusion after TEVAR, and moderate and large pleural effusion was an independent risk factor for near and long-term aortic related adverse events after TEVAR surgery.